IBDEI1DL ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24678,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24678,1,4,0)
 ;;=4^356.8
 ;;^UTILITY(U,$J,358.3,24678,1,5,0)
 ;;=5^Peripheral Neuropathy, Idiopathic
 ;;^UTILITY(U,$J,358.3,24678,2)
 ;;=Peripheral Neuropathy, Idio^268525
 ;;^UTILITY(U,$J,358.3,24679,0)
 ;;=337.20^^145^1530^100
 ;;^UTILITY(U,$J,358.3,24679,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24679,1,4,0)
 ;;=4^337.20
 ;;^UTILITY(U,$J,358.3,24679,1,5,0)
 ;;=5^Reflexive Sympathetic Dystrophy
 ;;^UTILITY(U,$J,358.3,24679,2)
 ;;=Reflexive Sympathetic Dystrophy^295799
 ;;^UTILITY(U,$J,358.3,24680,0)
 ;;=294.8^^145^1530^33
 ;;^UTILITY(U,$J,358.3,24680,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24680,1,4,0)
 ;;=4^294.8
 ;;^UTILITY(U,$J,358.3,24680,1,5,0)
 ;;=5^Dementia, Other
 ;;^UTILITY(U,$J,358.3,24680,2)
 ;;=^268044
 ;;^UTILITY(U,$J,358.3,24681,0)
 ;;=438.6^^145^1530^7
 ;;^UTILITY(U,$J,358.3,24681,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24681,1,4,0)
 ;;=4^438.6
 ;;^UTILITY(U,$J,358.3,24681,1,5,0)
 ;;=5^CVA w/Dysesthesia (late effect)
 ;;^UTILITY(U,$J,358.3,24681,2)
 ;;=CVA w/Dysesthesia (late effect)^328503
 ;;^UTILITY(U,$J,358.3,24682,0)
 ;;=438.7^^145^1530^26
 ;;^UTILITY(U,$J,358.3,24682,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24682,1,4,0)
 ;;=4^438.7
 ;;^UTILITY(U,$J,358.3,24682,1,5,0)
 ;;=5^CVA w/Vision Changes (late effect)
 ;;^UTILITY(U,$J,358.3,24682,2)
 ;;=CVA w/Vision Changes (late effect)^328504
 ;;^UTILITY(U,$J,358.3,24683,0)
 ;;=438.84^^145^1530^5
 ;;^UTILITY(U,$J,358.3,24683,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24683,1,4,0)
 ;;=4^438.84
 ;;^UTILITY(U,$J,358.3,24683,1,5,0)
 ;;=5^CVA w/Ataxia (late effect)
 ;;^UTILITY(U,$J,358.3,24683,2)
 ;;=CVA w/Ataxia (late effect)^328507
 ;;^UTILITY(U,$J,358.3,24684,0)
 ;;=434.91^^145^1530^27
 ;;^UTILITY(U,$J,358.3,24684,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24684,1,4,0)
 ;;=4^434.91
 ;;^UTILITY(U,$J,358.3,24684,1,5,0)
 ;;=5^CVA, Acute Onset
 ;;^UTILITY(U,$J,358.3,24684,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,24685,0)
 ;;=333.94^^145^1530^101
 ;;^UTILITY(U,$J,358.3,24685,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24685,1,4,0)
 ;;=4^333.94
 ;;^UTILITY(U,$J,358.3,24685,1,5,0)
 ;;=5^Restless Leg Syndrome
 ;;^UTILITY(U,$J,358.3,24685,2)
 ;;=^105368
 ;;^UTILITY(U,$J,358.3,24686,0)
 ;;=345.90^^145^1530^104
 ;;^UTILITY(U,$J,358.3,24686,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24686,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,24686,1,5,0)
 ;;=5^Seizure Disorder
 ;;^UTILITY(U,$J,358.3,24686,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,24687,0)
 ;;=907.0^^145^1530^73
 ;;^UTILITY(U,$J,358.3,24687,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24687,1,4,0)
 ;;=4^907.0
 ;;^UTILITY(U,$J,358.3,24687,1,5,0)
 ;;=5^Late Effect Intracranial Injury
 ;;^UTILITY(U,$J,358.3,24687,2)
 ;;=^68489
 ;;^UTILITY(U,$J,358.3,24688,0)
 ;;=339.00^^145^1530^43
 ;;^UTILITY(U,$J,358.3,24688,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24688,1,4,0)
 ;;=4^339.00
 ;;^UTILITY(U,$J,358.3,24688,1,5,0)
 ;;=5^Headache,Cluster NOS
 ;;^UTILITY(U,$J,358.3,24688,2)
 ;;=^336741
 ;;^UTILITY(U,$J,358.3,24689,0)
 ;;=339.01^^145^1530^42
 ;;^UTILITY(U,$J,358.3,24689,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24689,1,4,0)
 ;;=4^339.01
 ;;^UTILITY(U,$J,358.3,24689,1,5,0)
 ;;=5^Headache,Cluster Episodic
 ;;^UTILITY(U,$J,358.3,24689,2)
 ;;=^336545
 ;;^UTILITY(U,$J,358.3,24690,0)
 ;;=339.02^^145^1530^41
 ;;^UTILITY(U,$J,358.3,24690,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24690,1,4,0)
 ;;=4^339.02
 ;;^UTILITY(U,$J,358.3,24690,1,5,0)
 ;;=5^Headache,Cluster Chronic
 ;;^UTILITY(U,$J,358.3,24690,2)
 ;;=^336546
